Abstract
Background Non-communicable chronic diseases (NCDs) have become increasingly prominent in low- and middle-income countries (LMIC), driven by a rapid rise in their incidence. Current estimates suggest that these conditions account for approximately 80% of deaths in these regions. This study aimed to analyze the prevalence of NCDs and their associated risk factors in LMIC.
Methods Electronic searches were conducted in the PubMed, Embase, Scopus, Cochrane, and Virtual Health Library (VHL) databases between June and July 2023. Studies on the prevalence of NCDs, with or without associated risk factor analysis, were included. The quality of these studies was assessed using NIH tools, and a meta-analysis was conducted using the random-effects model.
Results A total of 34 studies on hypertension and 22 studies on diabetes were included in the systematic review and meta-analysis. The estimated prevalence of hypertension was 24% (95% CI: 21.0; 28.0) and diabetes mellitus (DM) was 11% (95% CI: 10.0; 13.0), with future predictions for similar populations ranging from 11.0-46.0% for hypertension and 6.0-21.0% for DM. Geographic analysis revealed a lower prevalence of hypertension in Latin America and the Caribbean (7.0%) with no statistically significant differences compared to other regions (p-value = 0.101). The prevalence of DM was lower in Sub-Saharan Africa (5.0%; p-value < 0.001). The identified risk factors for hypertension included increased age, male sex, elevated BMI, alcohol consumption, excessive salt intake, and stress. For diabetes, the risk factors were increased age, lack of religious affiliation, elevated BMI, family history of DM, hypertension, high hemoglobin concentration (HbA1c), waist-to-hip ratio, smoking, and infection with Taenia spp.
Conclusion NCDs such as hypertension and DM pose a growing public health challenge in low- and middle-income countries. Our findings may assist policymakers in identifying high-risk groups and recommending appropriate prevention strategies.
Systematic Review Registration The protocol was submitted for registration with the International Prospective Register of Systematic Reviews (PROSPERO) (registration number: CRD42024520601).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This systematic review and meta-analysis did not require ethical approval as it is based on previously published studies.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying the findings of this study are fully available and can be accessed without restriction. All relevant data are included within the manuscript and its supporting information files. Additional datasets generated or analyzed during the current study are available from the corresponding author upon reasonable request.
